Cancer Immunotherapy


Structural Biology Conference offers chance to the researches to discuss the most recent topic Cancer Immunotherapy which mainly focus on molecular mechanism of cancer initiation, cancer vaccines, non-specific immunotherapies, oncologic drug targets. The main aim of integrating structural biology data into cancer research is to design and discover novel and effective drugs to cure the disease. Structural biology combined with molecular modelling mainly aims at drug designing. Today’s most encouraging cancer therapy is immunotherapy. These treatments stimulate the patient’s immune system to destroy his/her cancer cells. Some drugs recognize specific molecules on the surface of cancer cells while others can bind to immune cells to help them kill cancer cells. This can be done mostly in two ways such as




  •  Stimulating your own immune system to work harder or smarter to attack cancer cells


  •  Giving you immune system components, such as man-made immune system proteins



Consequently, many Structural Biologists are conducting cancer research, to speed-up the process of understanding the mechanism of biomolecules in order to improve the newer cancer therapies.


    Related Conference of Cancer Immunotherapy

    June 13-14, 2024

    30th Asia Pacific Biotechnology Congress

    Dubai, UAE
    July 11-12, 2024

    6th International Conference on Biochemistry

    Paris, France
    September 25-26, 2024

    20th World Congress on Structural Biology

    Paris, France
    October 03-04, 2024

    15th International Conference on Biofuels and Bioenergy

    Singapore City, Singapore
    December 12-13, 2024

    15th World Congress on Cell & Tissue Science

    Rome, Italy

    Cancer Immunotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in